Nektar Therapeutics
NKTR
NKTR
199 hedge funds and large institutions have $1.78B invested in Nektar Therapeutics in 2016 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 101 increasing their positions, 34 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
3% more funds holding
Funds holding: 194 → 199 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
22% less capital invested
Capital invested by funds: $2.28B → $1.78B (-$503M)
Holders
199
Holding in Top 10
1
Calls
$8.72M
Puts
$7M
Top Buyers
| 1 | +$35.2M | |
| 2 | +$34.4M | |
| 3 | +$18.7M | |
| 4 |
Primecap Management
Pasadena,
California
|
+$17.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17M |
Top Sellers
| 1 | -$63M | |
| 2 | -$16.8M | |
| 3 | -$9.83M | |
| 4 |
PC
PointState Capital
New York
|
-$9.45M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.37M |